Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
MALE
NCT06425211

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.

Led by Boston Medical Group · Updated on 2026-01-23

66

Participants Needed

1

Research Sites

265 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this clinical trial is to evaluate the effectiveness of pelvic floor therapy for the management of erectile dysfunction and premature ejaculation in patients with erectile dysfunction and premature ejaculation. The main question to answer is: What is the effectiveness of pelvic floor therapy (electrostimulation, biofeedback, and therapeutic exercise) for the treatment of patients with erectile dysfunction and or premature ejaculation? Patients will: * Have an initial consultation of pelvic floor rehabilitation before therapy. * Be given pelvic floor therapy. * Have a secondary consultation of pelvic floor rehabilitation after therapy. Three intervention groups will be included: Group 1: Patients with premature ejaculation Group 2: Patients with erectile dysfunction Group 3: Patients with erectile dysfunction and premature ejaculation.

CONDITIONS

Official Title

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation.

Who Can Participate

Age: 18Years - 100Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male participants aged over 18 years
  • Erectile dysfunction or premature ejaculation lasting at least 6 months
  • Sexual activity with a heterosexual partner at least once a week
  • Signed informed consent before starting the study
  • For premature ejaculation group: Premature ejaculation diagnosis by ISSM criteria
  • Premature Ejaculation Diagnosis Tool (PEDT) score greater than 11
  • For erectile dysfunction group: Clinical diagnosis of primary erectile dysfunction
  • International Index Erectile Function - Erectile Function domain (IIEF-EF) score less than 26
Not Eligible

You will not qualify if you...

  • Pharmacological treatment for erectile dysfunction or premature ejaculation in the last 3 months
  • Erection Hardness Score greater than 3 for erectile dysfunction patients
  • History or suspicion of hypogonadism with Aging Males Symptoms (AMS) score greater than 36 for erectile dysfunction patients
  • History of pelvic radiotherapy
  • Presence of pacemaker, cardiac arrhythmia, or epilepsy
  • History of spinal cord trauma or spinal surgeries
  • Inability to attend therapies or follow-up visits
  • Illiteracy or cognitive disability preventing questionnaire completion
  • Psychiatric, psychological disorders, or cognitive deficiencies
  • Injuries in the therapy application area
  • Active pelvic organ cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Boston Medical Group Colombia

Bogotá, Cundinamarca, Colombia, 11022

Actively Recruiting

Loading map...

Research Team

C

Carolina Sandoval, Master

CONTACT

H

Héctor Corredor, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Effectiveness of Pelvic Floor Therapy for the Management of Erectile Dysfunction and Premature Ejaculation. | DecenTrialz